Three Scientists Win 2026 Nobel Prize for Optogenetics Breakthrough

Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Physiology or Medicine on October 5, 2026, for their discoveries in light-gated ion channels and optogenetics. The Nobel Assembly at Karolinska Institutet recognized their work as laying the foundation for a new era in neuroscience.

Hegemann and Nagel discovered channelrhodopsin, a light-sensitive protein found in the single-celled alga Chlamydomonas reinhardtii, in the early 2000s while working at Germany's Max Planck Institute for Biochemistry. When exposed to blue light, this protein opens a channel that allows charged ions to flow into cells, creating electrical impulses. Deisseroth, at Stanford University, adapted this natural mechanism into a practical neuroscience tool by introducing the channelrhodopsin gene into rat neurons, demonstrating in 2005 that blue light could trigger nerve signals with millisecond precision. By 2007, he had successfully applied this technique in the brains of living mice.

Optogenetics enables researchers to precisely control individual neurons and brain circuits using light, allowing them to map causal relationships between specific neural activity and behavior—a capability previously limited to observational correlation. The method has rapidly gained global adoption and is now widely used to study memory formation, emotions, addiction, motor control, and various neurological and psychiatric disorders. Clinical applications include research into restoring vision in people with visual impairment.

Deisseroth holds positions at the Howard Hughes Medical Institute and Stanford University in the United States. Hegemann is a professor at Humboldt University of Berlin, and Nagel is a professor at the University of Würzburg in Germany. The three laureates will share a prize of 12 million Swedish kronor (approximately 1.19 million U.S. dollars).